Mather Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $370K | Sell |
5,360
-573
| -10% | -$39.5K | ﹤0.01% | 448 |
|
|
2025
Q1 | $412K | Buy |
5,933
+345
| +6% | +$24K | ﹤0.01% | 418 |
|
|
2024
Q4 | $481K | Sell |
5,588
-247
| -4% | -$21.2K | 0.01% | 371 |
|
|
2024
Q3 | $695K | Buy |
5,835
+243
| +4% | +$28.9K | 0.01% | 296 |
|
|
2024
Q2 | $718K | Buy |
5,592
+1,546
| +38% | +$199K | 0.01% | 333 |
|
|
2024
Q1 | $419K | Sell |
4,046
-69
| -2% | -$7.14K | 0.01% | 375 |
|
|
2023
Q4 | $426K | Sell |
4,115
-5,663
| -58% | -$586K | 0.01% | 382 |
|
|
2023
Q3 | $889K | Buy |
9,778
+98
| +1% | +$8.91K | 0.02% | 232 |
|
|
2023
Q2 | $783K | Sell |
9,680
-128
| -1% | -$10.4K | 0.01% | 260 |
|
|
2023
Q1 | $780K | Sell |
9,808
-1,014
| -9% | -$80.7K | 0.01% | 251 |
|
|
2022
Q4 | $732K | Sell |
10,822
-96
| -0.9% | -$6.5K | 0.01% | 257 |
|
|
2022
Q3 | $544K | Buy |
10,918
+74
| +0.7% | +$3.69K | 0.01% | 277 |
|
|
2022
Q2 | $604K | Sell |
10,844
-6
| -0.1% | -$334 | 0.01% | 228 |
|
|
2022
Q1 | $602K | Buy |
10,850
+8
| +0.1% | +$444 | 0.01% | 232 |
|
|
2021
Q4 | $607K | Buy |
10,842
+8
| +0.1% | +$448 | 0.01% | 200 |
|
|
2021
Q3 | $520K | Sell |
10,834
-668
| -6% | -$32.1K | 0.01% | 166 |
|
|
2021
Q2 | $482K | Sell |
11,502
-200
| -2% | -$8.38K | 0.01% | 168 |
|
|
2021
Q1 | $394K | Sell |
11,702
-4,076
| -26% | -$137K | 0.01% | 173 |
|
|
2020
Q4 | $551K | Sell |
15,778
-3,004
| -16% | -$105K | 0.02% | 128 |
|
|
2020
Q3 | $652K | Sell |
18,782
-9,176
| -33% | -$319K | 0.03% | 115 |
|
|
2020
Q2 | $915K | Buy |
+27,958
| New | +$915K | 0.04% | 95 |
|